Welcome to our dedicated page for Cno Finl Group SEC filings (Ticker: CNO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The CNO Financial Group, Inc. (NYSE: CNO) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, along with AI-powered summaries to help interpret them. As a life and health insurer and financial services provider focused on middle-income America, CNO uses its filings to present detailed information on its insurance products, capital position and operating performance.
Investors can review CNO’s current reports on Form 8-K, which the company uses to furnish quarterly earnings press releases, quarterly financial supplements and additional financial and operating data. These filings commonly include metrics such as net income, net operating income, income from insurance products across annuity, health and life lines, fee income, investment income not allocated to product lines, and measures like book value per share and operating return on equity.
Over time, CNO’s SEC filings also provide insight into capital management and structure, including common stock dividends, share repurchase activity, reinsurance transactions with its wholly owned Bermuda reinsurance company, and technology modernization initiatives such as the TechMod project. Filings may describe changes in business mix, such as the decision to exit the fee services side of the Worksite Division to focus on core insurance offerings.
On Stock Titan, AI-generated highlights help explain the key points in lengthy documents, so users can quickly understand what each filing means for CNO’s insurance operations, investment portfolio and shareholders. Real-time updates from EDGAR ensure that new 8-Ks and other forms appear promptly, while tools for viewing insider-related information, capital actions and recurring reporting patterns make it easier to analyze CNO’s regulatory history.
Form 144 notice for proposed sale of CNO Financial Group, Inc. securities. The filing shows an intended sale of 4,862 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $184,655.84 and 96,931,934 shares outstanding. The approximate date of sale is listed as 08/14/2025 on the NYSE.
The filer reports acquisition details: 1,478 performance shares acquired 02/15/2024 and 3,384 restricted shares acquired 08/09/2024, both from the issuer. The filing also discloses sales during the past three months by Jeanne Linnenbringer totaling 6,420 common shares sold on 08/13/2025 with gross proceeds of $167,782.76 and $75,919.80.
Certain filer and issuer identifying fields (CIK, issuer name, contact details) are not populated in the provided text.
CNO Financial Group Form 144 discloses a proposed sale of common stock: 9,920 shares with an aggregate market value of $376,551.30, to be executed on the NYSE through Morgan Stanley Smith Barney LLC with an approximate sale date of 08/13/2025. The filing records 96,931,934 shares outstanding.
The shares were acquired from the issuer on 02/15/2024 as performance shares and payment is shown as Not Applicable. The filer reports Nothing to Report for securities sold during the past three months and makes the standard representation that they are not aware of undisclosed material adverse information about the issuer.
Form 144 notice for CNO Financial Group (CNO) reports a proposed sale of 6,420 common shares with an aggregate market value of $243,702.56. The shares are to be sold on the NYSE through Morgan Stanley Smith Barney LLC with an approximate sale date of 08/13/2025. Total shares outstanding reported are 96,931,934, giving readers the raw figures needed to assess scale.
The filing shows how the securities were acquired: 2,000 shares were restricted stock granted on 08/09/2024 and 4,420 were from a stock option exercise on 08/13/2025 paid in cash. The filer reports no sales in the past three months.
CNO Financial Group filed a Form S-8 to register an additional 2,000,000 shares of common stock for issuance under its Amended and Restated Long-Term Incentive Plan. The board adopted the amendment on February 12, 2025 and stockholders approved it on May 8, 2025. The amendment increases the number of shares reserved and the number of incentive stock options that may be granted by 2,000,000 shares and extends the plan termination to the day immediately prior to the tenth anniversary of stockholder approval.
The filing omits Part I prospectus text under Rule 428 and incorporates prior S-8 registration statements and recent Exchange Act filings by reference, including the Annual Report for the year ended December 31, 2024 (filed February 26, 2025) and quarterly reports filed May 7, 2025 and August 6, 2025.
CNO Financial Group, Inc. filed a Form S-8 to register an additional 1,600,000 shares of its common stock for issuance under the Amended and Restated Employee Stock Purchase Plan. The board adopted the amendment and restatement of the Plan on February 12, 2025, and the company’s stockholders approved the amendment on May 8, 2025. The additional shares increase the number of shares reserved for the Plan relative to the shares previously registered under the company’s prior Form S-8 (File No. 333-224819).
The Registration Statement incorporates by reference the company’s recent annual and quarterly reports and specified current reports, and it describes the company’s Delaware-based indemnification provisions and directors’ and officers’ insurance. The filing lists key exhibits, including the Amended and Restated Certificate of Incorporation, the Amended and Restated Bylaws, the ESPP document incorporated by reference, legal opinions and consents.